Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database.

Sterrantino G, Zaccarelli M, Di Biagio A, Biondi ML, Antinori A, Penco G; ARCA Study Group.

Infection. 2015 Jun;43(3):339-43. doi: 10.1007/s15010-015-0764-z. Epub 2015 Mar 28.

PMID:
25821204
2.

Darunavir-based dual therapy in HIV experienced patients.

Sterrantino G, Zaccarelli M, Di Biagio A, Rosi A, Bruzzone B, Cicconi P, Carli T, Biondi ML, Antinori A, Bartolozzi D, Penco G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19782. doi: 10.7448/IAS.17.4.19782. eCollection 2014.

3.

Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse.

Ferrari MM, Rossi G, Biondi ML, ViganĂ² P, Dell'utri C, Meschia M.

Arch Gynecol Obstet. 2012 Jun;285(6):1581-6. doi: 10.1007/s00404-011-2199-9. Epub 2011 Dec 31.

PMID:
22210296
4.

High resolution melting analysis to genotype the most common variants in the HFE gene.

Marotta RV, Turri O, Morandi A, Murano M, d'Eril GM, Biondi ML.

Clin Chem Lab Med. 2011 Sep;49(9):1453-7. doi: 10.1515/CCLM.2011.237. Epub 2011 Jun 1.

PMID:
21627541
5.

Detrimental effect of atazanavir plasma concentrations on total serum bilirubin levels in the presence of UGT1A1 polymorphisms.

Cicconi P, Bini T, Barassi A, Casana M, Turri O, Pateri F, Marchetti GC, Biondi ML, d'Eril GM, d'Arminio Manforte A.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e96-7. doi: 10.1097/QAI.0b013e318203e7e7. No abstract available.

6.

Role of fetuin-A in systemic sclerosis-associated calcinosis.

Belloli L, Ughi N, Massarotti M, Marasini B, Biondi ML, Brambilla G.

J Rheumatol. 2010 Dec;37(12):2638-9. doi: 10.3899/jrheum.100627. No abstract available.

PMID:
21123340
7.

[Laser ablation of placental vessels for treatment of severe twin-twin transfusion syndrome--experience from an university center in Brazil].

Peralta CF, Ishikawa LE, Bennini JR, Braga Ade F, Rosa IR, Biondi MC.

Rev Bras Ginecol Obstet. 2010 May;32(5):214-21. Portuguese.

8.

CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients.

Cozzolino M, Biondi ML, Banfi E, Riser BL, Mehmeti F, Cusi D, Gallieni M.

Blood Purif. 2010;30(4):272-6. doi: 10.1159/000320706. Epub 2010 Nov 11.

9.

MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation.

Lombardi F, Belletti S, Battezzati PM, Pacciolla R, Biondi ML.

J Cardiovasc Med (Hagerstown). 2011 Jan;12(1):37-42. doi: 10.2459/JCM.0b013e3283403366.

PMID:
20935575
10.

Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms.

Cozzolino M, Biondi ML, Galassi A, Cusi D, Brancaccio D, Gallieni M.

Blood Purif. 2010;29(4):347-51. doi: 10.1159/000302722. Epub 2010 Mar 31. Review.

11.

Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.

Cozzolino M, Biondi ML, Galassi A, Turri O, Brancaccio D, Gallieni M.

Nephrol Dial Transplant. 2009 Jul;24(7):2207-12. doi: 10.1093/ndt/gfp061. Epub 2009 Feb 16.

PMID:
19221176
12.

Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?

Carlo-Stella N, Belloli L, Biondi ML, Marasini B.

Clin Rheumatol. 2009 Feb;28(2):241-2. doi: 10.1007/s10067-008-1048-0. Epub 2008 Nov 28. No abstract available.

PMID:
19039512
13.

Genetic control of chemokines in severe human internal carotid artery stenosis.

Ghilardi G, Biondi ML, Turri O, Pateri F, d'Eril GM, Scorza R.

Cytokine. 2008 Jan;41(1):24-8. Epub 2007 Dec 3.

PMID:
18060801
14.

[Cardiac troponin-I elevations after thoracic surgery. Incidence and correlations with baseline clinical characteristics, C-reactive protein and perioperative parameters].

Lucreziotti S, Conforti S, Carletti F, Santaguida G, Meda S, Raveglia F, Tundo F, Panigalli T, Biondi ML, Mezzetti M, Fiorentini C.

Rev Esp Cardiol. 2007 Nov;60(11):1159-66. Spanish.

15.

Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus.

Marasini B, Massarotti M, De Monti M, Erario M, Ghilardi G, Biondi ML.

J Clin Immunol. 2008 Mar;28(2):131-3. Epub 2007 Nov 2.

PMID:
17975717
16.

Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.

Cozzolino M, Biondi ML, Galassi A, Gallieni M, d'Eril GV, Brancaccio D.

Am J Nephrol. 2007;27(6):639-42. Epub 2007 Sep 11.

PMID:
17851232
17.

Progression of coronary artery calcification in predialysis patients.

Russo D, Corrao S, Miranda I, Ruocco C, Manzi S, Elefante R, Brancaccio D, Cozzolino M, Biondi ML, Andreucci VE.

Am J Nephrol. 2007;27(2):152-8. Epub 2007 Feb 20.

PMID:
17312351
18.

Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients.

Cozzolino M, Galassi A, Biondi ML, Turri O, Papagni S, Mongelli N, Civita L, Gallieni M, Brancaccio D.

Am J Nephrol. 2006;26(5):423-9. Epub 2006 Sep 12.

PMID:
16968979
19.

PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity.

Scaglioni S, Verduci E, Salvioni M, Biondi ML, Radaelli G, Agostoni C, Giovannini M.

Pediatr Res. 2006 Oct;60(4):485-9. Epub 2006 Aug 28.

PMID:
16940242
20.

Decreased serum fetuin-A levels after a single haemodialysis session.

Cozzolino M, Galassi A, Biondi ML, Butti A, Russo M, Longhini C, Gallieni M, Brancaccio D.

Nephrol Dial Transplant. 2007 Jan;22(1):290-1. Epub 2006 Aug 18. No abstract available.

PMID:
16921184

Supplemental Content

Loading ...
Support Center